{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-046527","form_type":"8-K","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2022-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.924011+00:00","generated_at":"2026-06-26T07:12:13.844571+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"CFO Philippe Kurzweil resigns; President Jeff Rogers appointed CFO and Secretary","bullets":["Philippe J. Kurzweil resigned as CFO and Secretary, effective April 13, 2022.","Jeff Rogers appointed CFO and Secretary, effective same day; he continues as President.","Rogers has served as President since November 2021; biography incorporated by reference from Form 10-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-046527","json":"https://secwatch.observer/filing/0001104659-22-046527.json","markdown":"https://secwatch.observer/filing/0001104659-22-046527.md","text":"https://secwatch.observer/filing/0001104659-22-046527.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000110465922046527/0001104659-22-046527-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000110465922046527/tm2212817d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T07:12:13.844571+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d3c8c4beb2","claim":"Philippe J. Kurzweil resigned as Chief Financial Officer and Secretary at Tevogen Bio Holdings Inc..","evidence_excerpt":"On April 13, 2022, Philippe J. Kurzweil voluntarily resigned, effective immediately, as the Chief Financial Officer and Secretary of Semper Paratus Acquisition Corporation (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000110465922046527/0001104659-22-046527-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer and Secretary"}],"fact_type":"executive_change"},{"claim_id":"f80ca155c6","claim":"Jeff Rogers was appointed as Chief Financial Officer and Secretary at Tevogen Bio Holdings Inc..","evidence_excerpt":"Effective as of April 13, 2022, the Board of Directors of the Company appointed Jeff Rogers to serve as the Company’s Chief Financial Officer and Secretary.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860871/000110465922046527/0001104659-22-046527-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}